CH569021A5 - - Google Patents
Info
- Publication number
- CH569021A5 CH569021A5 CH112472A CH112472A CH569021A5 CH 569021 A5 CH569021 A5 CH 569021A5 CH 112472 A CH112472 A CH 112472A CH 112472 A CH112472 A CH 112472A CH 569021 A5 CH569021 A5 CH 569021A5
- Authority
- CH
- Switzerland
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D501/02—Preparation
- C07D501/04—Preparation from compounds already containing the ring or condensed ring systems, e.g. by dehydrogenation of the ring, by introduction, elimination or modification of substituents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D501/14—Compounds having a nitrogen atom directly attached in position 7
- C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
- C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
- C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
- C07D501/26—Methylene radicals, substituted by oxygen atoms; Lactones thereof with the 2-carboxyl group
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D501/14—Compounds having a nitrogen atom directly attached in position 7
- C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
- C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
- C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
- C07D501/26—Methylene radicals, substituted by oxygen atoms; Lactones thereof with the 2-carboxyl group
- C07D501/34—Methylene radicals, substituted by oxygen atoms; Lactones thereof with the 2-carboxyl group with the 7-amino radical acylated by carboxylic acids containing hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D501/14—Compounds having a nitrogen atom directly attached in position 7
- C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
- C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
- C07D501/57—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with a further substituent in position 7, e.g. cephamycines
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Cephalosporin Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB329571A GB1350772A (en) | 1971-01-27 | 1971-01-27 | Antibiotics and processes for their production |
| GB2852271 | 1971-06-17 | ||
| GB3965471 | 1971-08-24 | ||
| GB182972 | 1972-01-14 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CH569021A5 true CH569021A5 (cg-RX-API-DMAC7.html) | 1975-11-14 |
Family
ID=27447180
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CH112472A CH569021A5 (cg-RX-API-DMAC7.html) | 1971-01-27 | 1972-01-26 |
Country Status (10)
| Country | Link |
|---|---|
| JP (1) | JPS5418274B1 (cg-RX-API-DMAC7.html) |
| AR (1) | AR204899A1 (cg-RX-API-DMAC7.html) |
| AU (1) | AU468248B2 (cg-RX-API-DMAC7.html) |
| BE (1) | BE778508A (cg-RX-API-DMAC7.html) |
| CA (1) | CA1003404A (cg-RX-API-DMAC7.html) |
| CH (1) | CH569021A5 (cg-RX-API-DMAC7.html) |
| DE (1) | DE2203653C3 (cg-RX-API-DMAC7.html) |
| FR (1) | FR2161866B1 (cg-RX-API-DMAC7.html) |
| GB (1) | GB1350772A (cg-RX-API-DMAC7.html) |
| IE (1) | IE36192B1 (cg-RX-API-DMAC7.html) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3905963A (en) * | 1972-01-25 | 1975-09-16 | Lilly Co Eli | Process for preparing primary 3-carbamoyloxymethyl cephalosporins |
| US3994875A (en) * | 1974-06-24 | 1976-11-30 | Yeda Research & Development Co. Ltd. | Antibiotics |
| CA1128930A (en) | 1978-04-07 | 1982-08-03 | Stuart B. Laing | Cephalosporin compounds |
| WO1992019286A1 (en) * | 1991-05-03 | 1992-11-12 | University Technologies International, Inc. | Biofilm reduction method |
| WO2004083217A1 (en) * | 2003-03-20 | 2004-09-30 | Orchid Chemicals & Pharmaceuticals Ltd | An improved process for the preparation of cefoxitin |
| CN101830913B (zh) * | 2010-04-09 | 2012-10-31 | 烟台宝华生物技术有限公司 | 头孢母核衍生化合物、由其制备的头孢烯类鎓盐化合物及采用其制备硫酸头孢吡唑的方法 |
| CN103848851B (zh) * | 2012-11-29 | 2016-03-02 | 上海交通大学 | 一种盐酸头孢卡品酯的合成方法 |
| EP4241802A3 (en) | 2019-01-29 | 2023-10-18 | Nipro Corporation | Artificial lung device |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1445633A1 (de) | 1963-10-07 | 1968-12-05 | Ciba Geigy | Verfahren zur Herstellung neuer Amide |
| CH480365A (de) * | 1965-01-18 | 1969-10-31 | Ciba Geigy | Verfahren zur Herstellung neuer Derivate der 7-Aminocephalosporansäure |
-
1971
- 1971-01-27 GB GB329571A patent/GB1350772A/en not_active Expired
-
1972
- 1972-01-01 AR AR24020972A patent/AR204899A1/es active
- 1972-01-18 CA CA132,726A patent/CA1003404A/en not_active Expired
- 1972-01-24 IE IE8972A patent/IE36192B1/xx unknown
- 1972-01-26 CH CH112472A patent/CH569021A5/xx not_active IP Right Cessation
- 1972-01-26 BE BE778508A patent/BE778508A/xx unknown
- 1972-01-26 AU AU38356/72A patent/AU468248B2/en not_active Expired
- 1972-01-26 DE DE19722203653 patent/DE2203653C3/de not_active Expired
- 1972-01-27 FR FR7202751A patent/FR2161866B1/fr not_active Expired
- 1972-01-27 JP JP7210183A patent/JPS5418274B1/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| IE36192B1 (en) | 1976-09-15 |
| CA1003404A (en) | 1977-01-11 |
| IE36192L (en) | 1972-07-27 |
| FR2161866B1 (cg-RX-API-DMAC7.html) | 1975-08-01 |
| JPS5418274B1 (cg-RX-API-DMAC7.html) | 1979-07-06 |
| FR2161866A1 (cg-RX-API-DMAC7.html) | 1973-07-13 |
| BE778508A (fr) | 1972-07-26 |
| AU468248B2 (en) | 1976-01-08 |
| DE2203653B2 (de) | 1974-12-19 |
| GB1350772A (en) | 1974-04-24 |
| DE2203653C3 (de) | 1975-07-31 |
| AR204899A1 (es) | 1976-03-19 |
| AU3835672A (en) | 1973-08-02 |
| DE2203653A1 (de) | 1972-08-10 |
Similar Documents
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PL | Patent ceased | ||
| PL | Patent ceased |